This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Oxford Biodynamics Plc. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Francis Hector Grand
Introduction
Francis Hector Grand is a notable inventor based in Oxford, GB. He has made significant contributions to the field of cancer diagnostics through his innovative research and development. His work focuses on the application of epigenetic chromosomal interactions, which has the potential to revolutionize cancer prognostics.
Latest Patents
Francis Hector Grand holds a patent for the "Application of epigenetic chromosomal interactions in cancer diagnostics." This invention provides a method for determining the epigenetic chromosome interactions that are relevant to a prognostic companion epigenetic test for cancer. This advancement could lead to more accurate and personalized cancer treatment options.
Career Highlights
Grand is associated with Oxford Biodynamics Plc, a company that specializes in epigenetic technology. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research that aims to improve cancer diagnostics.
Collaborations
Some of his notable coworkers include Aroul Selvam Ramadass and Alexandre Akoulitchev. Their combined expertise enhances the innovative environment at Oxford Biodynamics Plc, fostering advancements in epigenetic research.
Conclusion
Francis Hector Grand's work exemplifies the intersection of innovation and healthcare, particularly in cancer diagnostics. His contributions are paving the way for future advancements in personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile